Free Newsletter
BioClinica adds heart, diagnostics savvy
Two contract researchers have joined BioClinica's certified partner program: Health Sciences International and PRL Central Laboratory Services. The former brings Phase I through IV expertise in cardiology, vascular disorders, and central nervous system conditions to the program, while the latter brings protocol-oriented diagnostic testing.
Health Sciences consults on R&D efforts, statistical analysis plan development, project and data management, and quality assurance. PRL provides validated diagnostic data management.
The partner program equips CROs with BioClinica trial management software and services. Offerings include interactive voice response, EDC, supply forecasting simulation, and compliant data management capabilities in addition to imaging services. Other program partners include MedSource, which specializes in oncology and early phase trials, and MMS Holding, an EDC specialist.
- see the announcement
Related Article:
Deal adds electronic tools to trial management services
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline

SHARE
WITH: